Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Wounds, Nonpenetrating | 3 | 2010 | 795 | 0.500 |
Why?
|
Warfarin | 12 | 2009 | 1497 | 0.350 |
Why?
|
Abdominal Injuries | 1 | 2009 | 352 | 0.270 |
Why?
|
Smoking Cessation | 8 | 2009 | 2071 | 0.270 |
Why?
|
Anticoagulants | 13 | 2009 | 4600 | 0.240 |
Why?
|
Atrial Fibrillation | 13 | 2009 | 5035 | 0.240 |
Why?
|
Spleen | 1 | 2010 | 2362 | 0.230 |
Why?
|
Neuromuscular Nondepolarizing Agents | 3 | 2002 | 146 | 0.230 |
Why?
|
Videotape Recording | 3 | 2009 | 352 | 0.230 |
Why?
|
Renal Dialysis | 6 | 2009 | 1783 | 0.220 |
Why?
|
Medical Order Entry Systems | 1 | 2007 | 545 | 0.210 |
Why?
|
Spinal Stenosis | 1 | 2005 | 255 | 0.200 |
Why?
|
Thromboembolism | 7 | 2009 | 987 | 0.200 |
Why?
|
Guideline Adherence | 3 | 2007 | 2265 | 0.200 |
Why?
|
Smoking | 9 | 2009 | 8987 | 0.170 |
Why?
|
Intracranial Hemorrhages | 5 | 2009 | 855 | 0.170 |
Why?
|
Nasal Septum | 1 | 2000 | 127 | 0.160 |
Why?
|
Anesthesia Recovery Period | 2 | 2007 | 157 | 0.160 |
Why?
|
Cerebral Hemorrhage | 6 | 2008 | 2647 | 0.160 |
Why?
|
Nasal Obstruction | 1 | 2000 | 151 | 0.150 |
Why?
|
AIDS Serodiagnosis | 2 | 2009 | 184 | 0.150 |
Why?
|
Gatekeeping | 3 | 2002 | 45 | 0.150 |
Why?
|
Data Collection | 3 | 2010 | 3339 | 0.150 |
Why?
|
Aged | 77 | 2010 | 163288 | 0.150 |
Why?
|
Female | 122 | 2010 | 380193 | 0.150 |
Why?
|
Prospective Studies | 33 | 2009 | 53290 | 0.150 |
Why?
|
Middle Aged | 82 | 2010 | 213390 | 0.150 |
Why?
|
Male | 107 | 2010 | 350115 | 0.140 |
Why?
|
New England | 2 | 2010 | 1022 | 0.140 |
Why?
|
Retrospective Studies | 40 | 2010 | 77460 | 0.140 |
Why?
|
Angina, Unstable | 3 | 2006 | 926 | 0.140 |
Why?
|
Colonic Diseases | 1 | 1998 | 202 | 0.140 |
Why?
|
Managed Care Programs | 4 | 2007 | 950 | 0.140 |
Why?
|
Specialization | 4 | 2008 | 776 | 0.140 |
Why?
|
Stroke | 14 | 2010 | 9981 | 0.140 |
Why?
|
Adult | 78 | 2010 | 214052 | 0.130 |
Why?
|
Trauma Centers | 3 | 2010 | 891 | 0.130 |
Why?
|
Operating Rooms | 3 | 2007 | 817 | 0.130 |
Why?
|
Bupropion | 2 | 2008 | 303 | 0.130 |
Why?
|
Recovery Room | 3 | 2006 | 32 | 0.130 |
Why?
|
Sciatica | 3 | 2006 | 98 | 0.130 |
Why?
|
Workers' Compensation | 3 | 2006 | 152 | 0.120 |
Why?
|
Cerebral Infarction | 5 | 2003 | 1011 | 0.120 |
Why?
|
Humans | 150 | 2010 | 744366 | 0.120 |
Why?
|
Isoquinolines | 3 | 2002 | 366 | 0.120 |
Why?
|
Fertilization in Vitro | 5 | 2001 | 1284 | 0.120 |
Why?
|
Neurofibroma, Plexiform | 2 | 2005 | 71 | 0.110 |
Why?
|
Terminal Care | 3 | 2009 | 1694 | 0.110 |
Why?
|
Anesthesia, Local | 2 | 2006 | 275 | 0.110 |
Why?
|
Aged, 80 and over | 36 | 2009 | 57776 | 0.110 |
Why?
|
Aminolevulinic Acid | 2 | 2006 | 142 | 0.110 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2009 | 264 | 0.110 |
Why?
|
Hospital Costs | 3 | 2008 | 985 | 0.110 |
Why?
|
Medicine | 4 | 2008 | 946 | 0.110 |
Why?
|
Recovery of Function | 5 | 2009 | 2926 | 0.110 |
Why?
|
Pancreatitis | 3 | 2008 | 1092 | 0.110 |
Why?
|
Logistic Models | 19 | 2009 | 13409 | 0.100 |
Why?
|
Advance Care Planning | 2 | 2009 | 662 | 0.100 |
Why?
|
Decision Making | 4 | 2009 | 3888 | 0.100 |
Why?
|
Brain Ischemia | 5 | 2010 | 3265 | 0.100 |
Why?
|
Counseling | 4 | 2009 | 1523 | 0.100 |
Why?
|
Academic Medical Centers | 5 | 2009 | 2760 | 0.100 |
Why?
|
Trauma Severity Indices | 2 | 2010 | 481 | 0.100 |
Why?
|
Kidney Failure, Chronic | 3 | 2008 | 2535 | 0.100 |
Why?
|
Cohort Studies | 22 | 2010 | 40559 | 0.100 |
Why?
|
Family Practice | 3 | 2005 | 516 | 0.100 |
Why?
|
Prenatal Care | 3 | 2008 | 1092 | 0.100 |
Why?
|
Lumbar Vertebrae | 3 | 2006 | 1848 | 0.100 |
Why?
|
Physicians, Women | 2 | 2008 | 486 | 0.100 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 667 | 0.100 |
Why?
|
Phosphorus | 2 | 2008 | 338 | 0.090 |
Why?
|
Hospital Units | 2 | 2008 | 141 | 0.090 |
Why?
|
Predictive Value of Tests | 18 | 2009 | 15078 | 0.090 |
Why?
|
Ovarian Hyperstimulation Syndrome | 3 | 1999 | 53 | 0.090 |
Why?
|
Cholecystectomy | 2 | 2008 | 395 | 0.090 |
Why?
|
Time Management | 2 | 2006 | 50 | 0.090 |
Why?
|
Emergency Service, Hospital | 7 | 2007 | 7658 | 0.090 |
Why?
|
Lidocaine | 2 | 2005 | 544 | 0.080 |
Why?
|
Health Maintenance Organizations | 2 | 2002 | 642 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2009 | 1956 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2009 | 2887 | 0.080 |
Why?
|
Creatine Kinase, MB Form | 2 | 2008 | 214 | 0.080 |
Why?
|
Gelsolin | 1 | 2009 | 190 | 0.080 |
Why?
|
Air Ambulances | 1 | 2009 | 90 | 0.080 |
Why?
|
Splenectomy | 1 | 2010 | 395 | 0.080 |
Why?
|
Proxy | 1 | 2009 | 145 | 0.080 |
Why?
|
Risk Factors | 22 | 2010 | 72296 | 0.080 |
Why?
|
Patient Education as Topic | 3 | 2008 | 2278 | 0.080 |
Why?
|
Patient Satisfaction | 5 | 2009 | 3395 | 0.080 |
Why?
|
Multivariate Analysis | 11 | 2009 | 12244 | 0.080 |
Why?
|
Antibodies, Anticardiolipin | 2 | 1999 | 62 | 0.080 |
Why?
|
Postpartum Period | 3 | 2009 | 1086 | 0.080 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2009 | 143 | 0.080 |
Why?
|
Ovarian Follicle | 2 | 2001 | 248 | 0.080 |
Why?
|
Community-Acquired Infections | 3 | 2001 | 465 | 0.080 |
Why?
|
Diverticulitis | 1 | 2010 | 171 | 0.080 |
Why?
|
Piperidines | 2 | 2009 | 1602 | 0.080 |
Why?
|
Early Ambulation | 1 | 2007 | 44 | 0.080 |
Why?
|
Kidney Diseases | 2 | 2009 | 2148 | 0.070 |
Why?
|
Prostatic Hyperplasia | 3 | 1996 | 523 | 0.070 |
Why?
|
Photochemotherapy | 2 | 2006 | 807 | 0.070 |
Why?
|
Treatment Failure | 2 | 2010 | 2618 | 0.070 |
Why?
|
Diagnostic Tests, Routine | 2 | 2003 | 783 | 0.070 |
Why?
|
Patient Care Management | 2 | 2007 | 306 | 0.070 |
Why?
|
Colonic Neoplasms | 2 | 1998 | 2542 | 0.070 |
Why?
|
Patient Admission | 2 | 2008 | 1380 | 0.070 |
Why?
|
Nicotine | 2 | 2009 | 681 | 0.070 |
Why?
|
Postanesthesia Nursing | 1 | 2006 | 12 | 0.070 |
Why?
|
Nitrogen Radioisotopes | 1 | 2006 | 44 | 0.070 |
Why?
|
Workload | 3 | 2007 | 849 | 0.070 |
Why?
|
Pyrazoles | 2 | 2009 | 1972 | 0.070 |
Why?
|
Twins | 1 | 2008 | 339 | 0.070 |
Why?
|
Coronary Disease | 4 | 2005 | 6077 | 0.070 |
Why?
|
Hematoporphyrin Photoradiation | 1 | 2005 | 17 | 0.070 |
Why?
|
Length of Stay | 7 | 2009 | 6311 | 0.070 |
Why?
|
Acute Disease | 9 | 2010 | 7147 | 0.070 |
Why?
|
Women | 1 | 2008 | 230 | 0.070 |
Why?
|
Treatment Outcome | 23 | 2009 | 63107 | 0.070 |
Why?
|
HIV Infections | 5 | 2010 | 16715 | 0.070 |
Why?
|
Periodicals as Topic | 2 | 2008 | 1431 | 0.070 |
Why?
|
Spinal Injuries | 1 | 2009 | 301 | 0.070 |
Why?
|
Proteinuria | 1 | 2009 | 658 | 0.070 |
Why?
|
Maternal Behavior | 1 | 2008 | 311 | 0.070 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 2006 | 58 | 0.070 |
Why?
|
Injury Severity Score | 1 | 2009 | 1014 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2009 | 3508 | 0.070 |
Why?
|
Emergency Medicine | 2 | 2005 | 1205 | 0.070 |
Why?
|
Gallstones | 1 | 2008 | 286 | 0.070 |
Why?
|
Myocardial Infarction | 5 | 2008 | 11718 | 0.070 |
Why?
|
Myoglobin | 1 | 2005 | 160 | 0.070 |
Why?
|
Bronchoconstriction | 1 | 2006 | 143 | 0.070 |
Why?
|
Nitric Oxide | 2 | 2004 | 2132 | 0.070 |
Why?
|
Police | 1 | 2007 | 149 | 0.070 |
Why?
|
Adolescent | 24 | 2009 | 85779 | 0.070 |
Why?
|
Anesthetics, Local | 2 | 2005 | 985 | 0.060 |
Why?
|
Massachusetts | 10 | 2010 | 8662 | 0.060 |
Why?
|
Physical Exertion | 1 | 2008 | 695 | 0.060 |
Why?
|
Postoperative Complications | 8 | 2010 | 15297 | 0.060 |
Why?
|
Steroids | 2 | 2002 | 930 | 0.060 |
Why?
|
Boston | 9 | 2010 | 9312 | 0.060 |
Why?
|
Afferent Pathways | 1 | 2006 | 302 | 0.060 |
Why?
|
Diagnostic Errors | 2 | 2009 | 1257 | 0.060 |
Why?
|
Extinction, Psychological | 1 | 2008 | 376 | 0.060 |
Why?
|
Angina Pectoris | 2 | 2005 | 977 | 0.060 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2004 | 88 | 0.060 |
Why?
|
Embryo Transfer | 2 | 1999 | 510 | 0.060 |
Why?
|
Depression, Postpartum | 1 | 2009 | 340 | 0.060 |
Why?
|
Carbon Monoxide | 2 | 2004 | 531 | 0.060 |
Why?
|
Brachial Plexus | 1 | 2006 | 163 | 0.060 |
Why?
|
Physicians, Family | 1 | 2006 | 345 | 0.060 |
Why?
|
Abdomen | 2 | 2008 | 1118 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2009 | 632 | 0.060 |
Why?
|
Aspirin | 4 | 2004 | 3283 | 0.060 |
Why?
|
Anti-HIV Agents | 2 | 2010 | 4255 | 0.060 |
Why?
|
Connective Tissue Diseases | 2 | 1997 | 264 | 0.060 |
Why?
|
Wounds and Injuries | 2 | 2009 | 2400 | 0.060 |
Why?
|
Cholinesterases | 2 | 2002 | 34 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2006 | 374 | 0.060 |
Why?
|
Photosensitizing Agents | 3 | 2006 | 602 | 0.060 |
Why?
|
Colectomy | 1 | 2009 | 680 | 0.060 |
Why?
|
Ambulatory Care | 3 | 2000 | 2708 | 0.060 |
Why?
|
Vitamin D | 2 | 2008 | 3224 | 0.060 |
Why?
|
Utilization Review | 2 | 2002 | 392 | 0.060 |
Why?
|
Medical Records | 3 | 2005 | 1413 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2008 | 1617 | 0.060 |
Why?
|
Neurites | 1 | 2006 | 388 | 0.060 |
Why?
|
Ovarian Neoplasms | 4 | 2005 | 4839 | 0.060 |
Why?
|
Hospital Information Systems | 1 | 2006 | 395 | 0.060 |
Why?
|
Adenocarcinoma | 5 | 2001 | 6364 | 0.060 |
Why?
|
Spinal Cord | 2 | 2003 | 1810 | 0.060 |
Why?
|
Mass Screening | 3 | 2009 | 5253 | 0.060 |
Why?
|
Porphyrins | 1 | 2005 | 348 | 0.060 |
Why?
|
Follicle Stimulating Hormone | 3 | 2001 | 744 | 0.060 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 503 | 0.060 |
Why?
|
Blood Flow Velocity | 3 | 2003 | 1423 | 0.060 |
Why?
|
Sensitivity and Specificity | 9 | 2008 | 14723 | 0.060 |
Why?
|
Bronchiolitis Obliterans | 1 | 2004 | 194 | 0.060 |
Why?
|
Authorship | 1 | 2006 | 271 | 0.060 |
Why?
|
Autonomic Nerve Block | 1 | 2003 | 72 | 0.060 |
Why?
|
Cervical Vertebrae | 1 | 2009 | 976 | 0.060 |
Why?
|
Ancillary Services, Hospital | 1 | 2002 | 23 | 0.060 |
Why?
|
Focus Groups | 1 | 2008 | 1321 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 2 | 2010 | 1205 | 0.050 |
Why?
|
Alfentanil | 1 | 2002 | 27 | 0.050 |
Why?
|
Malpractice | 1 | 2008 | 572 | 0.050 |
Why?
|
Patients | 1 | 2009 | 900 | 0.050 |
Why?
|
Disability Evaluation | 2 | 2008 | 1828 | 0.050 |
Why?
|
Bibliometrics | 1 | 2006 | 339 | 0.050 |
Why?
|
Triage | 1 | 2009 | 977 | 0.050 |
Why?
|
Anesthetics, Combined | 1 | 2002 | 40 | 0.050 |
Why?
|
Neurofibromatosis 1 | 2 | 2005 | 570 | 0.050 |
Why?
|
Fibrinolytic Agents | 4 | 2009 | 2158 | 0.050 |
Why?
|
Clostridium Infections | 1 | 2009 | 548 | 0.050 |
Why?
|
Longitudinal Studies | 5 | 2009 | 13991 | 0.050 |
Why?
|
Nerve Fibers | 1 | 2006 | 687 | 0.050 |
Why?
|
Digestive System Surgical Procedures | 1 | 2007 | 576 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 8 | 2009 | 20130 | 0.050 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2003 | 124 | 0.050 |
Why?
|
Pregnant Women | 1 | 2007 | 568 | 0.050 |
Why?
|
Anesthesia, Intravenous | 1 | 2002 | 130 | 0.050 |
Why?
|
Physical Examination | 1 | 2008 | 1237 | 0.050 |
Why?
|
Mental Recall | 1 | 2008 | 1206 | 0.050 |
Why?
|
Vascular Resistance | 1 | 2004 | 936 | 0.050 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2002 | 119 | 0.050 |
Why?
|
Accidents, Traffic | 1 | 2007 | 819 | 0.050 |
Why?
|
Community Health Services | 1 | 2007 | 650 | 0.050 |
Why?
|
Interdisciplinary Communication | 1 | 2007 | 950 | 0.050 |
Why?
|
Actins | 1 | 2009 | 2121 | 0.050 |
Why?
|
Weight Gain | 2 | 2009 | 2293 | 0.050 |
Why?
|
Low Back Pain | 3 | 2005 | 956 | 0.050 |
Why?
|
Troponin I | 1 | 2005 | 619 | 0.050 |
Why?
|
Hemorrhage | 4 | 2007 | 3461 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2010 | 1872 | 0.050 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2000 | 22 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2009 | 2166 | 0.050 |
Why?
|
Coronary Care Units | 1 | 2002 | 214 | 0.050 |
Why?
|
Odds Ratio | 7 | 2009 | 9849 | 0.050 |
Why?
|
International Cooperation | 1 | 2007 | 1420 | 0.050 |
Why?
|
Efficiency, Organizational | 1 | 2006 | 695 | 0.050 |
Why?
|
Carcinoma | 2 | 2005 | 2375 | 0.050 |
Why?
|
Dental Restoration Failure | 1 | 2001 | 152 | 0.050 |
Why?
|
Viral Load | 1 | 2010 | 3300 | 0.050 |
Why?
|
Diet, Atherogenic | 1 | 2000 | 95 | 0.050 |
Why?
|
Endometrial Neoplasms | 2 | 2001 | 1351 | 0.050 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5135 | 0.050 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2006 | 455 | 0.050 |
Why?
|
Diagnosis, Differential | 6 | 2003 | 12961 | 0.050 |
Why?
|
Quality Assurance, Health Care | 2 | 2001 | 2212 | 0.050 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2005 | 604 | 0.050 |
Why?
|
Follow-Up Studies | 14 | 2009 | 39052 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2007 | 1405 | 0.050 |
Why?
|
Obstetrics | 1 | 2008 | 658 | 0.050 |
Why?
|
Prostatic Neoplasms | 3 | 2009 | 11126 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 841 | 0.050 |
Why?
|
Electrosurgery | 1 | 2000 | 58 | 0.050 |
Why?
|
Injections, Epidural | 1 | 2002 | 195 | 0.050 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 641 | 0.050 |
Why?
|
Publishing | 1 | 2008 | 833 | 0.050 |
Why?
|
Prostatectomy | 1 | 2009 | 1890 | 0.050 |
Why?
|
Uterine Cervical Diseases | 1 | 2000 | 77 | 0.050 |
Why?
|
Graft Rejection | 2 | 2004 | 4397 | 0.050 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2006 | 685 | 0.050 |
Why?
|
Physician-Patient Relations | 4 | 2008 | 3229 | 0.050 |
Why?
|
Osseointegration | 1 | 2001 | 276 | 0.050 |
Why?
|
Epinephrine | 2 | 2005 | 792 | 0.050 |
Why?
|
Cholecystitis | 1 | 2001 | 182 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2004 | 976 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 1572 | 0.040 |
Why?
|
Ultraviolet Therapy | 1 | 2000 | 81 | 0.040 |
Why?
|
Pancreaticoduodenectomy | 2 | 2001 | 503 | 0.040 |
Why?
|
Burns | 2 | 2002 | 1815 | 0.040 |
Why?
|
Patch Tests | 1 | 1999 | 53 | 0.040 |
Why?
|
Pylorus | 1 | 2000 | 86 | 0.040 |
Why?
|
Survival Analysis | 7 | 2009 | 10252 | 0.040 |
Why?
|
Muscle Relaxation | 1 | 2000 | 142 | 0.040 |
Why?
|
Rhinitis, Allergic, Seasonal | 1 | 2000 | 99 | 0.040 |
Why?
|
Frozen Sections | 1 | 2000 | 155 | 0.040 |
Why?
|
Methotrexate | 1 | 2006 | 1728 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1081 | 0.040 |
Why?
|
Nerve Block | 1 | 2006 | 644 | 0.040 |
Why?
|
Peritoneal Neoplasms | 1 | 2005 | 665 | 0.040 |
Why?
|
Vitamins | 1 | 2008 | 1623 | 0.040 |
Why?
|
Postoperative Care | 1 | 2006 | 1487 | 0.040 |
Why?
|
Dermatitis, Contact | 1 | 1999 | 129 | 0.040 |
Why?
|
Age Factors | 9 | 2009 | 18373 | 0.040 |
Why?
|
Social Support | 1 | 2009 | 2118 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 8 | 2010 | 35425 | 0.040 |
Why?
|
California | 3 | 2009 | 1402 | 0.040 |
Why?
|
Glycoproteins | 2 | 1997 | 2266 | 0.040 |
Why?
|
Tyrosine | 1 | 2003 | 1462 | 0.040 |
Why?
|
Analgesia, Epidural | 1 | 2002 | 326 | 0.040 |
Why?
|
Time Factors | 13 | 2008 | 40075 | 0.040 |
Why?
|
Information Dissemination | 1 | 2007 | 1099 | 0.040 |
Why?
|
Antibodies, Antiphospholipid | 1 | 1999 | 69 | 0.040 |
Why?
|
Microcirculation | 1 | 2003 | 1287 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2009 | 1714 | 0.040 |
Why?
|
Vasospasm, Intracranial | 1 | 2001 | 208 | 0.040 |
Why?
|
Pulmonary Artery | 2 | 2004 | 1912 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2002 | 417 | 0.040 |
Why?
|
Oocytes | 3 | 1998 | 1188 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 3 | 2009 | 2560 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2003 | 3020 | 0.040 |
Why?
|
Unnecessary Procedures | 1 | 2002 | 432 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2001 | 226 | 0.040 |
Why?
|
Patient Care Team | 2 | 2007 | 2531 | 0.040 |
Why?
|
Ultrasonography | 6 | 2003 | 5984 | 0.040 |
Why?
|
Leadership | 1 | 2008 | 1357 | 0.040 |
Why?
|
Pneumonia, Bacterial | 1 | 2001 | 316 | 0.040 |
Why?
|
Cardiac Output | 1 | 2001 | 854 | 0.040 |
Why?
|
Mothers | 1 | 2009 | 2165 | 0.040 |
Why?
|
Endosonography | 1 | 2002 | 610 | 0.040 |
Why?
|
Severity of Illness Index | 8 | 2009 | 15535 | 0.040 |
Why?
|
Colitis, Ischemic | 1 | 1998 | 31 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2001 | 475 | 0.040 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 1997 | 289 | 0.040 |
Why?
|
Chest Pain | 1 | 2005 | 1114 | 0.040 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2009 | 1354 | 0.040 |
Why?
|
Ovarian Cysts | 1 | 1999 | 115 | 0.040 |
Why?
|
Survival Rate | 7 | 2009 | 12788 | 0.040 |
Why?
|
Heart Rate | 1 | 2009 | 4092 | 0.040 |
Why?
|
Patient Selection | 2 | 2008 | 4216 | 0.040 |
Why?
|
Pancuronium | 1 | 1997 | 45 | 0.040 |
Why?
|
Pregnancy Rate | 2 | 1999 | 643 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2008 | 1643 | 0.040 |
Why?
|
Tubocurarine | 1 | 1997 | 63 | 0.040 |
Why?
|
Vecuronium Bromide | 1 | 1997 | 33 | 0.040 |
Why?
|
Serotonin Antagonists | 1 | 1998 | 144 | 0.040 |
Why?
|
Employment | 2 | 2006 | 1132 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2008 | 2494 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2006 | 1181 | 0.040 |
Why?
|
Atracurium | 1 | 1997 | 52 | 0.040 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1999 | 224 | 0.040 |
Why?
|
Esophagectomy | 1 | 2001 | 447 | 0.040 |
Why?
|
Vitamin D Deficiency | 1 | 2007 | 1343 | 0.040 |
Why?
|
Ondansetron | 1 | 1998 | 90 | 0.040 |
Why?
|
Axons | 1 | 2006 | 1685 | 0.040 |
Why?
|
Virilism | 1 | 1997 | 31 | 0.040 |
Why?
|
Critical Pathways | 1 | 2001 | 476 | 0.040 |
Why?
|
Electric Stimulation Therapy | 1 | 2003 | 605 | 0.040 |
Why?
|
Estrogens, Non-Steroidal | 1 | 1997 | 54 | 0.040 |
Why?
|
Diethylstilbestrol | 1 | 1997 | 93 | 0.040 |
Why?
|
Hydronephrosis | 1 | 1998 | 269 | 0.040 |
Why?
|
Pregnancy | 11 | 2009 | 29144 | 0.040 |
Why?
|
Antiphospholipid Syndrome | 1 | 1999 | 173 | 0.040 |
Why?
|
Pneumonia | 2 | 2000 | 2133 | 0.040 |
Why?
|
Hypotension | 1 | 2003 | 884 | 0.040 |
Why?
|
Inhibins | 1 | 1997 | 211 | 0.040 |
Why?
|
International Normalized Ratio | 3 | 2004 | 367 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1641 | 0.040 |
Why?
|
Abdominal Pain | 1 | 2003 | 1064 | 0.040 |
Why?
|
Echocardiography, Doppler | 1 | 2001 | 935 | 0.040 |
Why?
|
Testicular Hormones | 1 | 1997 | 188 | 0.040 |
Why?
|
Health Policy | 1 | 2009 | 2661 | 0.040 |
Why?
|
Diverticulitis, Colonic | 1 | 1998 | 128 | 0.040 |
Why?
|
Models, Theoretical | 2 | 2007 | 3589 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2624 | 0.040 |
Why?
|
Gonadotropins | 1 | 1997 | 241 | 0.040 |
Why?
|
Ureteral Obstruction | 1 | 1998 | 296 | 0.040 |
Why?
|
Antiemetics | 1 | 1998 | 177 | 0.040 |
Why?
|
Child, Preschool | 9 | 2009 | 41005 | 0.040 |
Why?
|
Tobacco Industry | 1 | 1997 | 126 | 0.030 |
Why?
|
Cryptorchidism | 1 | 1997 | 125 | 0.030 |
Why?
|
Reproducibility of Results | 5 | 2009 | 19905 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2001 | 804 | 0.030 |
Why?
|
Tissue and Organ Procurement | 1 | 2004 | 896 | 0.030 |
Why?
|
Ascites | 1 | 1998 | 344 | 0.030 |
Why?
|
Prognosis | 9 | 2010 | 29060 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2002 | 935 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2004 | 1155 | 0.030 |
Why?
|
Growth Inhibitors | 1 | 1997 | 385 | 0.030 |
Why?
|
Propofol | 1 | 2002 | 629 | 0.030 |
Why?
|
Acne Vulgaris | 1 | 2000 | 302 | 0.030 |
Why?
|
Risk Assessment | 5 | 2009 | 23336 | 0.030 |
Why?
|
Interviews as Topic | 2 | 2009 | 2539 | 0.030 |
Why?
|
General Surgery | 1 | 2007 | 1636 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2008 | 5096 | 0.030 |
Why?
|
Mandible | 1 | 2000 | 740 | 0.030 |
Why?
|
Child Health Services | 1 | 2001 | 667 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2001 | 1579 | 0.030 |
Why?
|
Pancreas | 1 | 2002 | 1687 | 0.030 |
Why?
|
Health Status Indicators | 2 | 2003 | 970 | 0.030 |
Why?
|
Growth Substances | 1 | 1997 | 784 | 0.030 |
Why?
|
Gastrectomy | 1 | 2000 | 663 | 0.030 |
Why?
|
Blood Pressure | 2 | 2008 | 8551 | 0.030 |
Why?
|
Nausea | 1 | 1998 | 674 | 0.030 |
Why?
|
Case-Control Studies | 7 | 2009 | 21748 | 0.030 |
Why?
|
Confidence Intervals | 3 | 2008 | 2971 | 0.030 |
Why?
|
Dementia | 1 | 2009 | 2518 | 0.030 |
Why?
|
Vomiting | 1 | 1998 | 637 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2000 | 752 | 0.030 |
Why?
|
United States | 14 | 2009 | 69872 | 0.030 |
Why?
|
Child | 13 | 2009 | 77709 | 0.030 |
Why?
|
Infant | 7 | 2009 | 35134 | 0.030 |
Why?
|
Health Status | 2 | 2000 | 4034 | 0.030 |
Why?
|
Glioma | 1 | 2009 | 3401 | 0.030 |
Why?
|
Office Visits | 1 | 1999 | 598 | 0.030 |
Why?
|
Health Promotion | 1 | 2007 | 2205 | 0.030 |
Why?
|
Estrogens | 1 | 2001 | 1566 | 0.030 |
Why?
|
Anesthesia, General | 2 | 2002 | 1171 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2001 | 981 | 0.030 |
Why?
|
Kidney Calculi | 1 | 1998 | 465 | 0.030 |
Why?
|
Peroxidase | 1 | 1997 | 611 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4245 | 0.030 |
Why?
|
Hypertension, Pulmonary | 1 | 2004 | 1534 | 0.030 |
Why?
|
Program Evaluation | 2 | 2002 | 2488 | 0.030 |
Why?
|
Quality of Life | 3 | 2006 | 12802 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2000 | 1151 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2009 | 6539 | 0.030 |
Why?
|
Fever | 1 | 2001 | 1616 | 0.030 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1997 | 370 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2000 | 691 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3922 | 0.030 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2001 | 1018 | 0.030 |
Why?
|
Primary Health Care | 4 | 2005 | 4557 | 0.030 |
Why?
|
Dental Implants | 1 | 2001 | 750 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 1995 | 286 | 0.030 |
Why?
|
Exercise Test | 1 | 2001 | 2073 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2003 | 3070 | 0.030 |
Why?
|
Young Adult | 5 | 2010 | 56429 | 0.030 |
Why?
|
Telephone | 2 | 2007 | 617 | 0.030 |
Why?
|
Laser Therapy | 1 | 2000 | 1072 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2004 | 2119 | 0.030 |
Why?
|
World Health Organization | 2 | 2009 | 1318 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2001 | 1901 | 0.030 |
Why?
|
Autoantigens | 1 | 1997 | 892 | 0.030 |
Why?
|
Infusions, Intravenous | 3 | 2004 | 2274 | 0.030 |
Why?
|
Triglycerides | 1 | 2000 | 2453 | 0.030 |
Why?
|
Pyridines | 1 | 2004 | 2825 | 0.030 |
Why?
|
Aorta | 1 | 2000 | 2062 | 0.030 |
Why?
|
Comorbidity | 4 | 2009 | 10388 | 0.030 |
Why?
|
Health Care Costs | 2 | 2008 | 3208 | 0.030 |
Why?
|
Absorption | 2 | 2005 | 248 | 0.030 |
Why?
|
Postmenopause | 1 | 2001 | 2460 | 0.030 |
Why?
|
Regression Analysis | 4 | 2007 | 6459 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3841 | 0.030 |
Why?
|
Rheumatic Diseases | 1 | 1999 | 593 | 0.030 |
Why?
|
Patient Preference | 2 | 2009 | 889 | 0.030 |
Why?
|
Immunotherapy | 2 | 2005 | 4446 | 0.030 |
Why?
|
Skin | 1 | 2006 | 4372 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2001 | 2162 | 0.030 |
Why?
|
Cost Savings | 1 | 1997 | 925 | 0.030 |
Why?
|
Single-Blind Method | 3 | 2002 | 1590 | 0.030 |
Why?
|
Psoriasis | 1 | 2000 | 902 | 0.030 |
Why?
|
Infertility, Female | 1 | 1998 | 788 | 0.030 |
Why?
|
Intestine, Small | 1 | 1998 | 1240 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 1997 | 1073 | 0.030 |
Why?
|
Sheep | 2 | 2004 | 1437 | 0.030 |
Why?
|
Stents | 1 | 2003 | 3282 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1917 | 0.030 |
Why?
|
Cholesterol | 1 | 2000 | 2919 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2001 | 1585 | 0.020 |
Why?
|
Occupational Diseases | 1 | 2000 | 1469 | 0.020 |
Why?
|
Memory | 1 | 2001 | 2174 | 0.020 |
Why?
|
Chronic Disease | 5 | 2009 | 9145 | 0.020 |
Why?
|
Thigh | 2 | 2005 | 247 | 0.020 |
Why?
|
Heart Diseases | 2 | 2001 | 2789 | 0.020 |
Why?
|
Lipectomy | 2 | 2005 | 118 | 0.020 |
Why?
|
Recurrence | 3 | 2009 | 8340 | 0.020 |
Why?
|
Brain | 3 | 2010 | 26388 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2001 | 2795 | 0.020 |
Why?
|
Incidence | 6 | 2007 | 20952 | 0.020 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2000 | 1186 | 0.020 |
Why?
|
Double-Blind Method | 4 | 2009 | 12025 | 0.020 |
Why?
|
Epidural Space | 2 | 2002 | 124 | 0.020 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2008 | 4266 | 0.020 |
Why?
|
Pilot Projects | 4 | 2007 | 8319 | 0.020 |
Why?
|
Reoperation | 1 | 2000 | 4201 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2002 | 2737 | 0.020 |
Why?
|
Pain Measurement | 3 | 2008 | 3420 | 0.020 |
Why?
|
Endometriosis | 1 | 1998 | 839 | 0.020 |
Why?
|
Drug Costs | 1 | 1997 | 1105 | 0.020 |
Why?
|
Group Practice, Prepaid | 2 | 2001 | 14 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2002 | 2214 | 0.020 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2009 | 27 | 0.020 |
Why?
|
Myocardium | 1 | 2002 | 4772 | 0.020 |
Why?
|
Consent Forms | 1 | 2009 | 53 | 0.020 |
Why?
|
Hospitalization | 2 | 2006 | 10259 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 1997 | 1151 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2002 | 3112 | 0.020 |
Why?
|
Leukopenia | 1 | 2009 | 213 | 0.020 |
Why?
|
Thrombosis | 1 | 2002 | 2968 | 0.020 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2008 | 74 | 0.020 |
Why?
|
Causality | 2 | 2008 | 1275 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 9274 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2009 | 8861 | 0.020 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2008 | 141 | 0.020 |
Why?
|
Hospital Mortality | 3 | 2009 | 5316 | 0.020 |
Why?
|
Critical Care | 1 | 2001 | 2647 | 0.020 |
Why?
|
Cholangiography | 1 | 2008 | 189 | 0.020 |
Why?
|
Electric Stimulation | 2 | 2006 | 1767 | 0.020 |
Why?
|
Stroke Volume | 1 | 2001 | 5006 | 0.020 |
Why?
|
Leukocytosis | 1 | 2009 | 247 | 0.020 |
Why?
|
Asthma | 1 | 2006 | 6010 | 0.020 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2008 | 126 | 0.020 |
Why?
|
Pennsylvania | 1 | 2008 | 613 | 0.020 |
Why?
|
Cerebrovascular Circulation | 3 | 2002 | 2732 | 0.020 |
Why?
|
Coproporphyrinogen Oxidase | 1 | 2006 | 5 | 0.020 |
Why?
|
Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
Maine | 1 | 2006 | 139 | 0.020 |
Why?
|
Health Services for the Aged | 1 | 2009 | 269 | 0.020 |
Why?
|
Registries | 2 | 1999 | 8091 | 0.020 |
Why?
|
Evaluation Studies as Topic | 2 | 1999 | 1681 | 0.020 |
Why?
|
Nicotinic Agonists | 1 | 2009 | 271 | 0.020 |
Why?
|
Homocysteine | 1 | 2010 | 647 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 236 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2009 | 711 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2010 | 931 | 0.020 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2008 | 230 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2009 | 585 | 0.020 |
Why?
|
Activities of Daily Living | 2 | 2008 | 2419 | 0.020 |
Why?
|
Bronchoconstrictor Agents | 1 | 2006 | 77 | 0.020 |
Why?
|
Coronary Artery Disease | 2 | 2010 | 6486 | 0.020 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 2006 | 116 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2008 | 12356 | 0.020 |
Why?
|
Pediatrics | 1 | 2001 | 3475 | 0.020 |
Why?
|
Marital Status | 1 | 2008 | 437 | 0.020 |
Why?
|
Laparoscopy | 2 | 2009 | 2150 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 1999 | 3873 | 0.020 |
Why?
|
Methacholine Chloride | 1 | 2006 | 233 | 0.020 |
Why?
|
Protoporphyrins | 1 | 2006 | 164 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2008 | 349 | 0.020 |
Why?
|
Neoplasms | 2 | 2009 | 21696 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2002 | 4253 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 1998 | 1911 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2002 | 3677 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2007 | 339 | 0.020 |
Why?
|
Developed Countries | 1 | 2009 | 437 | 0.020 |
Why?
|
Manometry | 1 | 2008 | 445 | 0.020 |
Why?
|
Embryo Implantation | 2 | 1998 | 272 | 0.020 |
Why?
|
Cotinine | 1 | 2006 | 206 | 0.020 |
Why?
|
Risk | 3 | 2003 | 9688 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2008 | 504 | 0.020 |
Why?
|
Attitude to Health | 2 | 2008 | 2052 | 0.020 |
Why?
|
Observer Variation | 2 | 2003 | 2593 | 0.020 |
Why?
|
Vital Capacity | 1 | 2008 | 925 | 0.020 |
Why?
|
Crohn Disease | 1 | 1998 | 2304 | 0.020 |
Why?
|
Guanylate Cyclase-Activating Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
Administration, Oral | 2 | 2003 | 3914 | 0.020 |
Why?
|
Databases as Topic | 1 | 2007 | 475 | 0.020 |
Why?
|
Expert Testimony | 1 | 2008 | 356 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 425 | 0.020 |
Why?
|
Conditioning, Classical | 1 | 2008 | 366 | 0.020 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2004 | 68 | 0.020 |
Why?
|
Spirometry | 1 | 2008 | 865 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1997 | 2408 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2009 | 841 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5709 | 0.020 |
Why?
|
Parity | 1 | 2008 | 929 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 2 | 1999 | 780 | 0.020 |
Why?
|
Computer Systems | 1 | 2006 | 483 | 0.020 |
Why?
|
Disabled Persons | 2 | 2006 | 1212 | 0.020 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 254 | 0.020 |
Why?
|
Uncertainty | 1 | 2009 | 735 | 0.020 |
Why?
|
Video Recording | 1 | 2009 | 949 | 0.010 |
Why?
|
South Africa | 1 | 2009 | 1731 | 0.010 |
Why?
|
Patient Readmission | 2 | 2008 | 3116 | 0.010 |
Why?
|
Hospitals, University | 1 | 2005 | 570 | 0.010 |
Why?
|
Clinical Chemistry Tests | 1 | 2003 | 61 | 0.010 |
Why?
|
Prone Position | 1 | 2004 | 194 | 0.010 |
Why?
|
Creatinine | 1 | 2009 | 1919 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2004 | 6489 | 0.010 |
Why?
|
Health Resources | 1 | 2009 | 911 | 0.010 |
Why?
|
Drug Administration Schedule | 2 | 2002 | 4933 | 0.010 |
Why?
|
Cyclic GMP | 1 | 2004 | 409 | 0.010 |
Why?
|
Pulmonary Circulation | 1 | 2006 | 739 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2001 | 5263 | 0.010 |
Why?
|
Troponin T | 1 | 2008 | 754 | 0.010 |
Why?
|
Choice Behavior | 1 | 2009 | 802 | 0.010 |
Why?
|
Ambulances | 1 | 2003 | 95 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 1999 | 1537 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2009 | 1530 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2009 | 1461 | 0.010 |
Why?
|
Electrocardiography | 2 | 2008 | 6442 | 0.010 |
Why?
|
Schizophrenia | 1 | 2001 | 6882 | 0.010 |
Why?
|
Telemedicine | 1 | 1999 | 2872 | 0.010 |
Why?
|
Delphi Technique | 1 | 2005 | 779 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2003 | 528 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2006 | 417 | 0.010 |
Why?
|
Forms and Records Control | 1 | 2002 | 160 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2373 | 0.010 |
Why?
|
Embryo, Mammalian | 2 | 1998 | 1701 | 0.010 |
Why?
|
Prevalence | 3 | 2008 | 15221 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.010 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2009 | 980 | 0.010 |
Why?
|
Rehabilitation Centers | 1 | 2003 | 254 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1105 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2005 | 642 | 0.010 |
Why?
|
Models, Statistical | 2 | 2007 | 5101 | 0.010 |
Why?
|
Cell Biology | 1 | 2002 | 92 | 0.010 |
Why?
|
Disaster Planning | 1 | 2007 | 549 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2002 | 383 | 0.010 |
Why?
|
Oxygen | 2 | 2004 | 4189 | 0.010 |
Why?
|
Laminectomy | 1 | 2002 | 234 | 0.010 |
Why?
|
Urinalysis | 1 | 2003 | 369 | 0.010 |
Why?
|
Drug Synergism | 1 | 2005 | 1794 | 0.010 |
Why?
|
Referral and Consultation | 2 | 2007 | 3531 | 0.010 |
Why?
|
Conscious Sedation | 1 | 2006 | 528 | 0.010 |
Why?
|
Total Quality Management | 1 | 2002 | 274 | 0.010 |
Why?
|
Capillaries | 1 | 2004 | 773 | 0.010 |
Why?
|
RNA, Viral | 1 | 2009 | 2901 | 0.010 |
Why?
|
Estriol | 1 | 2000 | 53 | 0.010 |
Why?
|
Economics, Medical | 1 | 2001 | 113 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2297 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1999 | 9240 | 0.010 |
Why?
|
Memory Disorders | 1 | 2008 | 1186 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2007 | 1800 | 0.010 |
Why?
|
Allergy and Immunology | 1 | 2002 | 169 | 0.010 |
Why?
|
Neck | 1 | 2005 | 698 | 0.010 |
Why?
|
Cross-Sectional Studies | 3 | 2007 | 25039 | 0.010 |
Why?
|
Qualitative Research | 1 | 2009 | 2682 | 0.010 |
Why?
|
Platelet Aggregation | 1 | 2003 | 798 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 2001 | 277 | 0.010 |
Why?
|
Embolism | 1 | 2003 | 408 | 0.010 |
Why?
|
Cholesterol, Dietary | 1 | 2000 | 231 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 2003 | 537 | 0.010 |
Why?
|
Occupational Therapy | 1 | 2001 | 134 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2007 | 2453 | 0.010 |
Why?
|
Neuromuscular Junction | 1 | 2002 | 397 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2004 | 1150 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 2000 | 69 | 0.010 |
Why?
|
Form Perception | 1 | 2001 | 182 | 0.010 |
Why?
|
Career Choice | 1 | 2006 | 744 | 0.010 |
Why?
|
Waiting Lists | 1 | 2004 | 692 | 0.010 |
Why?
|
Blood Volume | 1 | 2001 | 565 | 0.010 |
Why?
|
Educational Status | 1 | 2008 | 2540 | 0.010 |
Why?
|
Drug Interactions | 1 | 2004 | 1460 | 0.010 |
Why?
|
Tumor Burden | 1 | 2005 | 1915 | 0.010 |
Why?
|
Ulnar Nerve | 1 | 2000 | 106 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2005 | 2029 | 0.010 |
Why?
|
Benchmarking | 1 | 2006 | 1042 | 0.010 |
Why?
|
Paraplegia | 1 | 2000 | 169 | 0.010 |
Why?
|
Cyclosporine | 1 | 2002 | 788 | 0.010 |
Why?
|
Fear | 1 | 2008 | 1440 | 0.010 |
Why?
|
Personnel, Hospital | 1 | 2001 | 283 | 0.010 |
Why?
|
Patient Transfer | 1 | 2006 | 762 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2006 | 4369 | 0.010 |
Why?
|
Haloperidol | 1 | 2000 | 397 | 0.010 |
Why?
|
Gastric Emptying | 1 | 2001 | 233 | 0.010 |
Why?
|
Spinal Cord Ischemia | 1 | 2000 | 94 | 0.010 |
Why?
|
Hydrostatic Pressure | 1 | 1999 | 106 | 0.010 |
Why?
|
Blood | 1 | 2001 | 598 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1375 | 0.010 |
Why?
|
Ovulation Induction | 1 | 2001 | 274 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 8949 | 0.010 |
Why?
|
Algorithms | 3 | 2006 | 13882 | 0.010 |
Why?
|
Maxilla | 1 | 2001 | 471 | 0.010 |
Why?
|
Health Benefit Plans, Employee | 1 | 2001 | 332 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2291 | 0.010 |
Why?
|
Receptors, LHRH | 1 | 1999 | 160 | 0.010 |
Why?
|
Heart Valves | 1 | 2000 | 291 | 0.010 |
Why?
|
Administration, Topical | 1 | 2000 | 690 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2000 | 876 | 0.010 |
Why?
|
Dermatitis | 1 | 2000 | 199 | 0.010 |
Why?
|
Motivation | 1 | 2008 | 1971 | 0.010 |
Why?
|
Menotropins | 1 | 1998 | 45 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2002 | 924 | 0.010 |
Why?
|
Posture | 1 | 2002 | 958 | 0.010 |
Why?
|
Motor Skills | 1 | 2001 | 522 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5953 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2008 | 1831 | 0.010 |
Why?
|
Hypertension | 2 | 2010 | 8479 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1660 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 2001 | 535 | 0.010 |
Why?
|
Physical Therapy Modalities | 1 | 2001 | 550 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2003 | 1572 | 0.010 |
Why?
|
Dental Implantation, Endosseous | 1 | 2001 | 502 | 0.010 |
Why?
|
Wakefulness | 1 | 2004 | 1245 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2005 | 6313 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1180 | 0.010 |
Why?
|
Urography | 1 | 1998 | 313 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2005 | 2383 | 0.010 |
Why?
|
New York | 1 | 2000 | 886 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 1999 | 455 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1873 | 0.010 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 535 | 0.010 |
Why?
|
Myeloblastin | 1 | 1997 | 101 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2000 | 10943 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4222 | 0.010 |
Why?
|
Body Temperature | 1 | 2000 | 777 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2000 | 1107 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2428 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2001 | 1098 | 0.010 |
Why?
|
Follistatin | 1 | 1997 | 141 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2000 | 387 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2002 | 1677 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6366 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 429 | 0.010 |
Why?
|
Mullerian Ducts | 1 | 1997 | 198 | 0.010 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7282 | 0.010 |
Why?
|
Demography | 1 | 2001 | 1655 | 0.010 |
Why?
|
Radiographic Image Enhancement | 1 | 2001 | 885 | 0.010 |
Why?
|
Disorders of Sex Development | 1 | 1997 | 122 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2003 | 9955 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1999 | 980 | 0.010 |
Why?
|
Developing Countries | 1 | 2009 | 2815 | 0.010 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2000 | 450 | 0.010 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2000 | 507 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5882 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 1999 | 4561 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 2001 | 11031 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2009 | 3680 | 0.010 |
Why?
|
Communication | 1 | 2009 | 3750 | 0.010 |
Why?
|
Arthroscopy | 1 | 2002 | 926 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 2003 | 1372 | 0.010 |
Why?
|
Shoulder Joint | 1 | 2002 | 695 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5388 | 0.010 |
Why?
|
Bone Transplantation | 1 | 2000 | 907 | 0.010 |
Why?
|
Urban Population | 1 | 2003 | 2022 | 0.010 |
Why?
|
Washington | 1 | 1996 | 313 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 2288 | 0.010 |
Why?
|
Tissue Donors | 1 | 2004 | 2241 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2585 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2001 | 1203 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 6994 | 0.010 |
Why?
|
Sjogren's Syndrome | 1 | 1996 | 234 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 1997 | 402 | 0.010 |
Why?
|
Palliative Care | 1 | 2009 | 3493 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2009 | 25628 | 0.010 |
Why?
|
Reaction Time | 1 | 2001 | 2098 | 0.010 |
Why?
|
Epithelium | 1 | 1999 | 1679 | 0.010 |
Why?
|
Fertility | 1 | 1999 | 781 | 0.010 |
Why?
|
Emergencies | 1 | 2001 | 1170 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2000 | 804 | 0.010 |
Why?
|
Rabbits | 1 | 2000 | 4894 | 0.010 |
Why?
|
Calcium | 1 | 2007 | 5755 | 0.010 |
Why?
|
Databases, Factual | 1 | 2009 | 7730 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1998 | 638 | 0.010 |
Why?
|
Myositis | 1 | 1996 | 251 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 2001 | 1678 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2006 | 3611 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2002 | 4777 | 0.010 |
Why?
|
Cerebellum | 1 | 2001 | 1488 | 0.010 |
Why?
|
Testis | 1 | 1997 | 804 | 0.010 |
Why?
|
Self-Assessment | 1 | 1996 | 390 | 0.010 |
Why?
|
Dopamine | 1 | 2001 | 1591 | 0.010 |
Why?
|
Hospitals | 1 | 2007 | 3954 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1997 | 1950 | 0.010 |
Why?
|
Cryopreservation | 1 | 1998 | 670 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2001 | 2190 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8642 | 0.010 |
Why?
|
Knee Joint | 1 | 2002 | 1680 | 0.010 |
Why?
|
Patient Discharge | 1 | 2006 | 3318 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2001 | 1739 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1996 | 995 | 0.010 |
Why?
|
Scleroderma, Systemic | 1 | 1996 | 323 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 5984 | 0.010 |
Why?
|
Sweden | 1 | 1995 | 1341 | 0.010 |
Why?
|
Vasculitis | 1 | 1996 | 519 | 0.010 |
Why?
|
Allergens | 1 | 1999 | 1320 | 0.010 |
Why?
|
Age of Onset | 1 | 1999 | 3270 | 0.010 |
Why?
|
Hysterectomy | 1 | 1998 | 927 | 0.010 |
Why?
|
Research Support as Topic | 1 | 1996 | 705 | 0.010 |
Why?
|
Commerce | 1 | 1997 | 592 | 0.010 |
Why?
|
Forecasting | 1 | 2001 | 2951 | 0.010 |
Why?
|
Animals | 4 | 2005 | 168768 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2001 | 2417 | 0.010 |
Why?
|
Cost of Illness | 1 | 2001 | 1860 | 0.010 |
Why?
|
Radiography | 1 | 2002 | 7023 | 0.010 |
Why?
|
Aging | 1 | 2010 | 8664 | 0.010 |
Why?
|
Infertility | 1 | 1998 | 655 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10400 | 0.010 |
Why?
|
Urology | 1 | 1995 | 399 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10483 | 0.010 |
Why?
|
Biopsy | 1 | 2002 | 6755 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 6234 | 0.010 |
Why?
|
Probability | 1 | 1995 | 2506 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9724 | 0.010 |
Why?
|
Estradiol | 1 | 1997 | 2020 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2001 | 2569 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2006 | 16690 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9584 | 0.010 |
Why?
|
Feasibility Studies | 1 | 1999 | 5077 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2005 | 8432 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1998 | 1400 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2006 | 11486 | 0.010 |
Why?
|
Body Weight | 1 | 2000 | 4671 | 0.010 |
Why?
|
Health Expenditures | 1 | 2001 | 2349 | 0.010 |
Why?
|
Critical Illness | 1 | 2001 | 2670 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11366 | 0.000 |
Why?
|
Sepsis | 1 | 2001 | 2593 | 0.000 |
Why?
|
Research | 1 | 1995 | 1999 | 0.000 |
Why?
|
Testosterone | 1 | 1997 | 2419 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1998 | 2020 | 0.000 |
Why?
|
Obesity | 1 | 2008 | 12746 | 0.000 |
Why?
|
Heart Failure | 1 | 2009 | 10895 | 0.000 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1996 | 2104 | 0.000 |
Why?
|
Body Mass Index | 1 | 2001 | 12721 | 0.000 |
Why?
|
Cognition | 1 | 2001 | 6770 | 0.000 |
Why?
|
Societies, Medical | 1 | 1995 | 3743 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7182 | 0.000 |
Why?
|
Clinical Competence | 1 | 1998 | 4687 | 0.000 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1998 | 4034 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13693 | 0.000 |
Why?
|
Arthritis, Rheumatoid | 1 | 1996 | 3712 | 0.000 |
Why?
|
Physicians | 1 | 1999 | 4567 | 0.000 |
Why?
|
Mice | 1 | 2005 | 81201 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 11525 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1998 | 13104 | 0.000 |
Why?
|